Record $9.6M Q1 Revenue for electroCore, Adjusted EBITDA Loss Narrows to $2.3M
ECOR sits 68% above its 52-week low of $4.16 on light trading volume (0.3× avg).
Summary
electroCore reported record first-quarter 2026 net sales of $9.6 million, marking a 43% year-over-year increase, and significantly narrowed its adjusted EBITDA loss to $2.3 million from $3.1 million a year prior. This positive financial update, which also highlighted an improved gross margin of 87%, comes after the company disclosed substantial doubt about its ability to continue as a going concern in its recent 10-K filing. The strong revenue growth, driven by its VA channel and Quell product line, and reduced losses are crucial in addressing these prior financial viability concerns. Investors will be closely watching for sustained operational improvements and continued progress towards profitability, especially as the company reiterates its full-year 2026 revenue guidance of approximately 30% growth.
At the time of this announcement, ECOR was trading at $7.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.8M. The 52-week trading range was $4.16 to $8.64. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.